Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationStem CellsTissue DonorsGraft SurvivalLeukemiaBusulfanLiver TransplantationHistocompatibility TestingHistocompatibilityHematopoiesisTreatment OutcomeAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationCombined Modality TherapyRetrospective StudiesRemission InductionImmunosuppressive AgentsHematopoietic Stem Cell MobilizationKidney TransplantationGraft vs Leukemia EffectCyclophosphamideTransplantation, IsogeneicAntigens, CD34Leukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseMyeloablative AgonistsBone and BonesMice, Inbred C57BLChimerismTime FactorsCell DifferentiationHematologic DiseasesHLA AntigensTransplantation ImmunologyMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSevere Combined ImmunodeficiencySurvival AnalysisBone Marrow PurgingMultiple MyelomaSurvival RateGraft RejectionGraft vs Tumor EffectLymphocyte TransfusionColony-Forming Units AssayCell TransplantationDisease-Free SurvivalMesenchymal Stem Cell TransplantationLymphocyte DepletionFlow CytometryMelphalanAcute DiseaseImmunosuppressionCell LineageT-LymphocytesLymphoma, Non-HodgkinBone Marrow DiseasesLeukemia, MyeloidHeart TransplantationGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsSiblingsRadiation ChimeraAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesVidarabineUnrelated DonorsAntilymphocyte SerumLung TransplantationOrgan TransplantationCells, CulturedSalvage TherapyFetal BloodStem Cell NicheCyclosporineCell SeparationCytarabineOpportunistic InfectionsEmbryonic Stem CellsPrognosisAdult Stem CellsLeukocyte TransfusionTransplantationImmunocompromised HostLymphoproliferative Disorders